Exact Mass: 363.0905

Exact Mass Matches: 363.0905

Found 42 metabolites which its exact mass value is equals to given mass value 363.0905, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cefadroxil

(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O5S (363.0889)

Cefadroxil is only found in individuals that have used or taken this drug. It is a long-acting, broad-spectrum, water-soluble, cephalexin derivative.Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3662

Benzoximate

Pesticide4_Benzoximate_C18H18ClNO5_Methanone, (benzoyloxy)(3-chloro-2,6-dimethoxyphenyl)-, O-ethyloxime, (Z)-

C18H18ClNO5 (363.0873)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters

7-Methyl-2'-deoxyguanosine-3'-monophosphate

{[5-(6-hydroxy-2-imino-7-methyl-3,7,8,9-tetrahydro-2H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonate

C11H18N5O7P (363.0944)

Etofibrate

2-(Pyridine-3-carbonyloxy)ethyl 2-(4-chlorophenoxy)-2-methylpropanoic acid

C18H18ClNO5 (363.0873)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites

CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3178; ORIGINAL_PRECURSOR_SCAN_NO 3177 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3195; ORIGINAL_PRECURSOR_SCAN_NO 3193 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3168; ORIGINAL_PRECURSOR_SCAN_NO 3166 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3180; ORIGINAL_PRECURSOR_SCAN_NO 3179 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3178; ORIGINAL_PRECURSOR_SCAN_NO 3176 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3179; ORIGINAL_PRECURSOR_SCAN_NO 3177

5-NITRO-2-(4-NITROPHENYL)BENZANILIDE

C19H13N3O5 (363.0855)

Thiazolidine, 3-[(4-ethoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C18H21NO3S2 (363.0963)

LOXITANE C

Loxapine hydrochloride

C18H19Cl2N3O (363.0905)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

tert-Butyl 6-bromospiro[indene-1,4-piperidine]-1-carboxylate

C18H22BrNO2 (363.0834)

Celestine blue

C.I. Mordant Blue 14 (8CI)

C17H18ClN3O4 (363.0986)

4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophene-7-carbaldehyde

C21H17NO3S (363.0929)

Methacrylic acid, 2-hydroxyethyl ester diphenyl phosphate

C18H20O6P (363.0997)

NF 49

C21H17NO3S (363.0929)

Trimethyl[2-[(trimethylsilyl)methyl]benzyl]ammonium Iodide

C14H26INSi (363.0879)

2-Hydroxy Cephalexin

C16H17N3O5S (363.0889)

7,8-diethoxy-4-oxo-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylic acid ethyl ester

C16H17N3O5S (363.0889)

Cephalexin Sulfoxide

C16H17N3O5S (363.0889)

Vonoprazan Impurity 3

C17H15F2N3O2S (363.0853)

(3-Chloro-2,6-dimethoxyphenyl)(ethoxyimino)methyl benzoate

C18H18ClNO5 (363.0873)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters

N-(4-chloroanilino)-N-(4-chlorophenyl)-3,3-dimethyl-2-oxobutanimidamide

C18H19Cl2N3O (363.0905)

H-Asp-Asp-Asp-OH

C12H17N3O10 (363.0914)

(6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O5S (363.0889)

Metcamifen

C16H17N3O5S (363.0889)

[n-(Benzyloxycarbonyl)amino](4-amidinophenyl)methane-phosphonate

C16H18N3O5P (363.0984)

Etofibrate

C18H18ClNO5 (363.0873)

Benzoic acid [2-oxo-2-[2-(phenylthio)anilino]ethyl] ester

C21H17NO3S (363.0929)

1-(4-Chlorophenyl)-5-[1-(2-oxolanylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione

C17H18ClN3O4 (363.0986)

2,4,6-Tris(4-fluorophenyl)pyrylium

C23H14F3O+ (363.0997)

(4R)-2-[2-[(S)-amino-(4-hydroxyphenyl)methyl]-5-hydroxy-1,3-oxazol-4-yl]-5,5-dimethyl-4H-1,3-thiazole-4-carboxylic acid

C16H17N3O5S (363.0889)

Cefadroxil

C16H17N3O5S (363.0889)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins A cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Asp-Asp-Asp

C12H17N3O10 (363.0914)

(2r,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O5S (363.0889)